(Q34116570)

31 July 2017

1 reference

title

Pharmacogenomics and addiction to opiates (English)

1 reference

31 July 2017

1 reference

3

Maier W

1 reference

31 July 2017

Lichtermann D

1

1 reference

31 July 2017

Franke P

series ordinal

2

1 reference

31 July 2017

Rao ML

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

European Journal of Pharmacology

31 July 2017

published in

1 reference

31 July 2017

volume

410

1 reference

31 July 2017

issue

2-3

1 reference

31 July 2017

page(s)

269-279

1 reference

Morphine self-administration in mu-opioid receptor-deficient mice

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Chromosome Mapping of Gene Loci Affecting Morphine and Amphetamine Responses in BXD Recombinant Inbred Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Voluntary consumption of morphine in 15 inbred mouse strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Localization to chromosome 10 of a locus influencing morphine analgesia in crosses derived from C57BL/6 and DBA/2 strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Region-specific up-regulation of opioid receptor binding in enkephalin knockout mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Chronic morphine and naltrexone fail to modify mu-opioid receptor mRNA levels in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Cannabinoid receptor gene (CNR1): association with i.v. drug use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Genetic animal models of alcohol and drug abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Identifying genes for alcohol and drug sensitivity: recent progress and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Dopamine receptors and dopamine transporter in brain function and addictive behaviors: insights from targeted mouse mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Agonist selective mu-opioid receptor trafficking in rat central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Opiate drugs: 'guilt by association'

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Human delta-opioid receptor gene and susceptibility to heroin and alcohol dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

DRD4 exon III VNTR polymorphism—susceptibility factor for heroin dependence? Results of a case-control and a family-based association approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

D4 dopamine-receptor (DRD4) alleles and novelty seeking in substance-dependent, personality-disorder, and control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Use of recombinant inbred strains to identify quantitative trait loci in psychopharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Genetic and environmental risk factors in the aetiology of illicit drug initiation and subsequent misuse in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Hallucinogen, opiate, sedative and stimulant use and abuse in a population-based sample of female twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Acute morphine dependence in mice selectively-bred for high and low analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Opioids: first lessons from knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

No heroin or morphine 6beta-glucuronide analgesia in mu-opioid receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

No association between the serotonin transporter promoter region (5-HTTLPR) and the dopamine D3 receptor (BalI D3DR) polymorphisms and heroin addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Association analysis of the dopamine D4 gene exon III VNTR and heroin abuse in Chinese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Support for allelic association of a polymorphic site in the promoter region of the serotonin transporter gene with risk for alcohol dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Genomics, gene expression and DNA arrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Absence of opiate rewarding effects in mice lacking dopamine D2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Genetic variability in morphine sensitivity and tolerance between different strains of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Association between a delta opioid receptor gene polymorphism and heroin dependence in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

The use of single-nucleotide polymorphism maps in pharmacogenomics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Rewarding effects of opiates are absent in mice lacking the receptor for substance P.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Molecular and cellular basis of addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Comparison of G-protein activation in the brain by mu-, delta-, and kappa-opioid receptor agonists in mu-opioid receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

D2 dopamine receptor gene TaqI A1 and B1 restriction fragment length polymorphisms: enhanced frequencies in psychostimulant-preferring polysubstance abusers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Genome-wide search for genes affecting the risk for alcohol dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

The future of genetic studies of complex human diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

The neurochemistry of morphine addiction in the neocortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Quantitative autoradiography of mu-,delta- and kappa1 opioid receptors in kappa-opioid receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

The dopamine hypothesis of reward: past and current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Increased rewarding properties of morphine in dopamine-transporter knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Evidence for an association between heroin dependence and a VNTR polymorphism at the serotonin transporter locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Forward and reverse genetic approaches to behavior in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Genetic and environmental influences on transitions in drug use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Chronic opioid antagonist administration upregulates mu opioid receptor binding without altering mu opioid receptor mRNA levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

An association between a microsatellite polymorphism at the DRD5 gene and the liability to substance abuse: pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Acute intermittent morphine increases preprodynorphin and kappa opioid receptor mRNA levels in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Cocaine and the serotonin saga

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Getting the brain's attention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Steady-state methadone in rats does not change mRNA levels of corticotropin-releasing factor, its pituitary receptor or proopiomelanocortin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

A study of oral morphine preference in inbred mouse strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900820-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(00)00820-7

1 reference

31 July 2017

1 reference